Australia markets closed

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
107.39+0.06 (+0.06%)
As of 12:11PM EST. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5189.64B
Enterprise value 3268.16B
Trailing P/E 39.48
Forward P/E 17.78
PEG ratio (5-yr expected) 11.90
Price/sales (ttm)4.14
Price/book (mrq)14.50
Enterprise value/revenue 35.86
Enterprise value/EBITDA 612.10

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 325.22%
S&P500 52-week change 323.92%
52-week high 3113.41
52-week low 362.55
50-day moving average 3107.31
200-day moving average 397.92

Share statistics

Avg vol (3-month) 37.37M
Avg vol (10-day) 36.98M
Shares outstanding 51.77B
Float 1.74B
% held by insiders 10.10%
% held by institutions 170.00%
Shares short (11 Feb 2021) 414.28M
Short ratio (11 Feb 2021) 41.85
Short % of float (11 Feb 2021) 40.81%
Short % of shares outstanding (11 Feb 2021) 40.81%
Shares short (prior month 14 Jan 2021) 412.59M

Dividends & splits

Forward annual dividend rate 45.2
Forward annual dividend yield 44.84%
Trailing annual dividend rate 34.84
Trailing annual dividend yield 34.51%
5-year average dividend yield 44.14
Payout ratio 4173.53%
Dividend date 315 Feb 2021
Ex-dividend date 413 Apr 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 10.08%
Operating margin (ttm)34.27%

Management effectiveness

Return on assets (ttm)8.19%
Return on equity (ttm)187.70%

Income statement

Revenue (ttm)45.8B
Revenue per share (ttm)27.48
Quarterly revenue growth (yoy)59.20%
Gross profit (ttm)31.75B
EBITDA 22.17B
Net income avi to common (ttm)4.56B
Diluted EPS (ttm)2.72
Quarterly earnings growth (yoy)-98.70%

Balance sheet

Total cash (mrq)8.49B
Total cash per share (mrq)4.81
Total debt (mrq)87.1B
Total debt/equity (mrq)665.02
Current ratio (mrq)0.84
Book value per share (mrq)7.41

Cash flow statement

Operating cash flow (ttm)17.59B
Levered free cash flow (ttm)16.86B